Managers’ Stock-Based Compensation and Disclosures of High Proprietary Cost Information : An Investigation of US Biotech Firms
Year of publication: |
2020
|
---|---|
Authors: | Enache, Luminita |
Other Persons: | Kim, Jae B. (contributor) |
Publisher: |
[2020]: [S.l.] : SSRN |
Subject: | Biotechnologie-Industrie | Biotechnology industry | Führungskräfte | Managers | Unternehmenspublizität | Corporate disclosure | Theorie | Theory | Asymmetrische Information | Asymmetric information | Prinzipal-Agent-Theorie | Agency theory | USA | United States | Börsenkurs | Share price | Aktienoption | Stock option |
-
Chapter 4. Executive Compensation: Where We Are, and How We Got There
Murphy, Kevin J., (2013)
-
Right on Schedule : CEO Option Grants and Opportunism
Daines, Robert, (2016)
-
Ironing Out the Kinks in Executive Compensation : Linking Incentive Pay to Average Stock Prices
Tian, Yisong Sam, (2012)
- More ...
-
Managers’ stock-based compensation and disclosures of high proprietary cost information
Enache, Luminita, (2019)
-
Enache, Luminita, (2018)
-
RESOLUTION OF FINANCIAL DISTRESS: A COMPARATIVE ANALYSIS OF U.S., U.K., AND JAPANESE FIRMS
AJAYI, Richard A., (2012)
- More ...